BioGenCell is a seed startup based in Israel. 1 investor tracked on Brouky Intelligence. Status: zombie. Data sourced from Brouky Intelligence.
About
BioGenCell is developing a novel platform for automated manufacturing of personalized cell therapies that induce the regeneration of blood vessels, for the treatment of severe limb-threatening ischemia.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky